Niagen Bioscience Inc (NAGE)
NASDAQ: NAGE
· Real-Time Price · USD
12.94
1.43 (12.42%)
At close: Jun 06, 2025, 3:59 PM
13.07
1.00%
After-hours: Jun 06, 2025, 05:58 PM EDT
12.42% (1D)
| Bid | 13 |
| Market Cap | 1.02B |
| Revenue (ttm) | 107.92M |
| Net Income (ttm) | 14.11M |
| EPS (ttm) | 0.18 |
| PE Ratio (ttm) | 71.89 |
| Forward PE | 50.96 |
| Analyst | Buy |
| Ask | 13.2 |
| Volume | 1,134,119 |
| Avg. Volume (20D) | 838,025 |
| Open | 11.94 |
| Previous Close | 11.51 |
| Day's Range | 11.82 - 13.11 |
| 52-Week Range | 2.31 - 13.12 |
| Beta | 2.08 |
About NAGE
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NAGE
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NAGE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 day ago
Niagen Bioscience shares are trading higher after ...
Unlock content with
Pro Subscription
1 month ago
+9.35%
Niagen Bioscience shares are trading higher after the company reported better-than-expected Q1 financial results and raised its fY25 revenue guidance.
1 month ago · businesswire.com
Niagen Bioscience Welcomes Dr. Pinchas Cohen to Scientific Advisory BoardLOS ANGELES--(BUSINESS WIRE)---- $NAGE #Bioscience--Niagen Bioscience, Inc. (NASDAQ: NAGE) (formerly ChromaDex Corp.), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on ...
2 months ago · businesswire.com
Niagen Bioscience Confirms Its Operations Remain Unaffected by New TariffsLOS ANGELES--(BUSINESS WIRE)---- $NAGE #Bioscience--Niagen Bioscience, Inc. (NASDAQ: NAGE) (formerly ChromaDex Corp.), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on ...
